Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01926587
Title Oral Rigosertib in Combination With Azacitidine
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Indications

bone marrow cancer

acute myeloid leukemia

chronic myeloid leukemia

Therapies

Azacitidine + Regorafenib

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.